Gene · 2255
Papers3,603
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 3,603
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Structural basis for FGF hormone signalling. | Nature | 2023 | 37286607 | PubTator, text mining | PubMed |
| Identification of necroptosis-related genes in Parkinson's disease by integrated bioinformatics analysis and experimental validation. | Front Neurosci | 2023 | 37284660 | PubTator, text mining | PubMed |
| Enhancement of CAR-T cell activity against cholangiocarcinoma by simultaneous knockdown of six inhibitory membrane proteins. | Cancer Commun (Lond) | 2023 | 37282786 | PubTator, text mining | PubMed |
| Development of cancer-associated fibroblast-related gene signature for predicting the survival and immunotherapy response in lung adenocarcinoma. | Aging (Albany NY) | 2023 | 37280069 | PubTator, text mining | PubMed |
| Deciphering the single-cell transcriptome network in keloids with intra-lesional injection of triamcinolone acetonide combined with 5-fluorouracil. | Front Immunol | 2023 | 37275903 | PubTator, text mining | PubMed |
| Developmental impairments of craniofacial bone and cartilage in transgenic mice expressing FGF10. | Bone Rep | 2023 | 37275784 | PubTator, text mining | PubMed |
| Pancreatic β-cell heterogeneity in adult human islets and stem cell-derived islets. | Cell Mol Life Sci | 2023 | 37270452 | PubTator, text mining | PubMed |
| Delivery of FGF10 by implantable porous gelatin microspheres for treatment of spinal cord injury. | Mol Med Rep | 2023 | 37264963 | PubTator, text mining | PubMed |
| RTK signalling promotes epithelial columnar cell shape and apical junction maintenance in human lung progenitor cells. | Development | 2023 | 37260147 | PubTator, text mining | PubMed |
| Developmental regulation of conserved non-coding element evolution provides insights into limb loss in squamates. | Sci China Life Sci | 2023 | 37256419 | PubTator, text mining | PubMed |
| Hydrogel-in-hydrogel live bioprinting for guidance and control of organoids and organotypic cultures. | Nat Commun | 2023 | 37253730 | PubTator, text mining | PubMed |
| Fibroblast Growth Factor 11 Enables Tumor Cell Immune Escape by Promoting T Cell Exhaustion and Predicts Poor Prognosis in Patients with Lung Adenocarcinoma. | J Oncol | 2023 | 37250453 | PubTator, text mining | PubMed |
| Dental Pulp Stem Cells for Salivary Gland Regeneration-Where Are We Today? | Int J Mol Sci | 2023 | 37240009 | PubTator, text mining | PubMed |
| Rapid Generation of Pulmonary Organoids from Induced Pluripotent Stem Cells by Co-Culturing Endodermal and Mesodermal Progenitors for Pulmonary Disease Modelling. | Biomedicines | 2023 | 37239147 | PubTator, text mining | PubMed |
| Targeting receptor tyrosine kinase signaling: Avenues in the management of cutaneous squamous cell carcinoma. | iScience | 2023 | 37235052 | PubTator, text mining | PubMed |
| Combining Poly-(ARD-Ribose) Polymerase and Programmed Cell Death Protein 1 Inhibition in a Patient with Esophagogastric Adenocarcinoma. | Oncol Res Treat | 2023 | 37231946 | PubTator, text mining | PubMed |
| Therapeutic targeting of P2X4 receptor and mitochondrial metabolism in clear cell renal carcinoma models. | J Exp Clin Cancer Res | 2023 | 37231503 | PubTator, text mining | PubMed |
| Short report galectins use N-glycans of FGFs to capture growth factors at the cell surface and fine-tune their signaling. | Cell Commun Signal | 2023 | 37231412 | PubTator, text mining | PubMed |
| Transit Amplifying Cells (TACs): a still not fully understood cell population. | Front Bioeng Biotechnol | 2023 | 37229487 | PubTator, text mining | PubMed |
| Amelogenesis imperfecta: Next-generation sequencing sheds light on Witkop's classification. | Front Physiol | 2023 | 37228816 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2255/papers?page=21